Unesbulin

Drug identity checked against registry records

Also recorded as PTC596

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)NCT05269355PTC TherapeuticsPhase 2, Phase 3Terminated2024-06-17Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.